Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Antibiotic-coated Braided Suture Study

NCT: NCT07322289 · NOT_YET_RECRUITING

NCT IDNCT07322289
StatusNOT_YET_RECRUITING
Start Date2026-11-01
Completion2027-12-31
SponsorUniversity of Miami (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate whether the use of antibiotic-coated (triclosan) braided sutures is non-inferior or potentially superior to standard monofilament sutures in patients with prosthetic joint infections (PJIs) managed with the DAIR protocol. Several studies in various surgical specialties have demonstrated the effectiveness and non-inferiority of triclosan-coated braided sutures in infected surgical cases, and the study intends to transpose this idea to the management of prosthetic joint infections. Monofilament sutures are the present standard of care in any infected joint case due their lower surface area for bacterial harborization, though surgeons sacrifice mechanical integrity and comfortability with the closure in the process. By demonstrating the safety of antibiotic -coated braided sutures, surgeons will no longer have to make this compromise.

Frequently Asked Questions

What is Antibiotic-coated Braided Suture Study?

Antibiotic-coated Braided Suture Study is a clinical trial registered under NCT07322289. Current status: NOT_YET_RECRUITING.

What is the status of NCT07322289?

The current status of NCT07322289 (Antibiotic-coated Braided Suture Study) is: NOT_YET_RECRUITING.

When did Antibiotic-coated Braided Suture Study start?

Antibiotic-coated Braided Suture Study started on 2026-11-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.